Avanos Financial Statements From 2010 to 2024

8HH Stock   18.60  0.70  3.91%   
Avanos Medical financial statements provide useful quarterly and yearly information to potential Avanos Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Avanos Medical financial statements helps investors assess Avanos Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Avanos Medical's valuation are summarized below:
Avanos Medical does not presently have any fundamental signals for analysis.
Check Avanos Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avanos Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Avanos financial statements analysis is a perfect complement when working with Avanos Medical Valuation or Volatility modules.
  
This module can also supplement various Avanos Medical Technical models . Check out the analysis of Avanos Medical Correlation against competitors.
For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

Avanos Medical Company EBITDA Analysis

Avanos Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Avanos Medical EBITDA

    
  122.9 M  
Most of Avanos Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avanos Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition
According to the company disclosure, Avanos Medical reported earnings before interest,tax, depreciation and amortization of 122.9 M. This is much higher than that of the sector and significantly higher than that of the EBITDA industry. The ebitda for all Germany stocks is notably lower than that of the firm.

Avanos Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Avanos Medical's current stock value. Our valuation model uses many indicators to compare Avanos Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avanos Medical competition to find correlations between indicators driving Avanos Medical's intrinsic value. More Info.
Avanos Medical is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for Avanos Medical is about  1,389,667,120 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avanos Medical's earnings, one of the primary drivers of an investment's value.

About Avanos Medical Financial Statements

Avanos Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Avanos Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Avanos Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Avanos Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.